Jim Simons Rani Therapeutics Holdings, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
37Shares Held
3.01MCall Options Held
2KPut Options Held
3.1K-
Vanguard Group Inc Valley Forge, PA710KShares$1.82 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.27 Million1.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.15 Million0.07% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$802,0840.03% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$442,7100.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $62.9M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...